Holding(s) in Company

RNS Number : 0943P
Proteome Sciences PLC
18 March 2009
 


For filings with the FSA include the annex
For filings with issuer exclude the annex 


TR-1: Notifications of Major Interests in Shares


1. Identity of the issuer or the underlying issuer of existing 
shares to which voting rights are attached:

Proteome Sciences plc

2. Reason for notification

[Yes/No]

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of financial instruments which may result in the 
acquisition of shares already issued to which voting rights are attached 

No

An event changing the breakdown of voting rights

No

Other (please specify):

No

3. Full name of person(s) subject to notification 
obligation:

Sanofi-Aventis Deutschland GmbH

4. Full name of shareholder(s) (if different from 3):

   

5. Date of transaction (and date on which the 
threshold is crossed or reached if different):

17 March 2009

6. Date on which issuer notified:

18 March 2009

7. Threshold(s) that is/are crossed or reached:

9%



8: Notified Details

A: Voting rights attached to shares


Class/type of 
shares

Situation previous to 
the triggering 
transaction

Resulting situation after 
the triggering transaction

If possible use 
ISIN code

Number of shares

Number of 
voting rights

Number of shares

Number of 
voting rights

Percentage of 
voting rights





Direct

Indirect

Direct

Indirect

GB0003104196

12,286,187

12,286,187

10,859,124

10,859,124

-

8.18%

-










B: Financial Instruments

Resulting situation after the triggering transaction


Type of financial instrument

Expiration date

Exercise/ conversion period/date

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

N/A

N/A

N/A

N/A

N/A








Total (A+B)


Number of voting rights

Percentage of voting rights

10,859,124

8.18%



9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:



Proxy Voting:

10. Name of proxy holder:


11. Number of voting rights proxy 
holder will cease to hold:


12. Date on which proxy holder will 
cease to hold voting rights:



13. Additional information:


14 Contact name:

Juergen Blieke or Reiner May

15. Contact telephone name:

0049 69 305 4703 or 0049 69 305 80202


For notes on how to complete form TR-1 please see the FSA website. 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGUUGAWUPBGQR
UK 100

Latest directors dealings